carbon group molecular entity clomipramine Beilstein:1323477 CHEBI:3754 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12 314.15498 Patent:US3467650 GDLIGKIOYRNHDA-UHFFFAOYSA-N chebi_ontology CHEBI:47780 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine Reaxys:1323477 monochlorimipramine Drug_Central:701 CAS:303-49-1 PMID:19747949 G 34586 0 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine DrugBank:DB01242 Patent:CH371799 3-chloroimipramine PMID:12084414 A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias. LINCS:LSM-3171 3-(3-CHLORO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE KEGG:C06918 PDBeChem:CXX 314.85210 CHEBI:47359 PMID:12007764 chlorimipramine PMID:16085036 C19H23ClN2 InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3 Wikipedia:Clomipramine PMID:19810911 Clomipramine PMID:17471183 KEGG:D07727